Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database

Background Diclofenac, a nonsteroidal anti-inflammatory drug, is not a documented cause of rhabdomyolysis in the Summaries of Product Characteristics held by major regulators. There are, however, eight published single case reports that associate rhabdomyolysis with diclofenac. Objective Triggered b...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs - real world outcomes 2021-09, Vol.8 (3), p.263-275
Hauptverfasser:	Russom, Mulugeta, Fitsum, Yodit, Abraham, Abiel, Savage, Ruth L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Arthritis Case reports Causality Data mining FDA approval Health risks Information retrieval Internal Medicine Kidneys Kinases Medicine Medicine & Public Health Nonsteroidal anti-inflammatory drugs Original Original Research Article Patients Pharmacology/Toxicology Pharmacotherapy Pharmacovigilance Rhabdomyolysis Side effects Statins Uric acid Urine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!